# Vir Biotechnology, Inc. (VIR)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/VIR/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 238.92M | $ -45.62M | $ -142.26M | $ 93.27M | $ 982.49M |
| 2025 | $ 70.20M | $ -448.46M | $ -401.15M | $ 186.91M | $ 765.28M |
| 2024 | $ 78.00M | $ -548.62M | $ -476.83M | $ 97.89M | $ 1.15B |
| 2023 | $ 93.18M | $ -665.04M | $ -865.39M | $ 124.54M | $ 1.59B |
| 2022 | $ 1.81B | $ 576.24M | $ 1.78B | $ 127.97M | $ 2.08B |
| 2021 | $ 1.30B | $ 628.30M | $ -82.50M | $ 137.49M | $ 1.43B |
| 2020 | $ 92.33M | $ -380.48M | $ -251.59M | $ 70.18M | $ 716.85M |
| 2019 | $ 1.70M | $ -225.47M | $ -178.86M | $ 237.0K | $ 423.94M |
| 2018 | $ 6.31M | $ -153.05M | $ -137.39M | $ 10.14M | $ -179.18M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.09 |
| Liabilities / Eq | 0.24 |
| Current Ratio | 6.04 |

## Other views

- [Metrics](https://sponda.capital/en/VIR.md)
- [Charts](https://sponda.capital/en/VIR/charts.md)
- [Compare](https://sponda.capital/en/VIR/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.